Brainsway (BRSYF) Other Non-Current Liabilities (2024 - 2025)
Brainsway posted quarterly Other Non-Current Liabilities of $14.7 million for Q4 2025, up 503.38% year-on-year from $2.4 million in Q4 2024, and up 503.38% on a QoQ basis from $2.4 million in Q4 2024.
Brainsway (BRSYF) has 2 years of Other Non-Current Liabilities data on file, last reported at $14.7 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Liabilities rose 503.38% year-over-year to $14.7 million; the trailing twelve-month figure through Dec 2025 stood at $14.7 million (up 503.38% YoY), and the FY2025 full-year result was $14.7 million, up 503.38% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $14.7 million, up from $2.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $14.7 million in Q4 2025 and bottomed at $2.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Brainsway | - | - | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.66 Mn |
| Dec 31, 2024 | 2.43 Mn |